Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SHILPA MEDICARE Plunges 6%; BSE HEALTHCARE Index Down 0.0%
Thu, 19 Sep 15:40

SHILPA MEDICARE Plunges 6%; BSE HEALTHCARE Index Down 0.0%Image source: Nikada/www.istockphoto.com

SHILPA MEDICARE share price has plunged 6% and is presently trading at Rs 860.0.

Meanwhile, the BSE HEALTHCARE index is at 43,755.5 .

Among the top losers in the BSE HEALTHCARE index today are FDC (down 5.1%) and GSK Pharma (down 3.6%).

MAX HEALTHCARE INSTITUTE (up 3.5%) and SUVEN PHARMACEUTICALS (up 3.1%) are among the top gainers today.

Over the last one year, SHILPA MEDICARE has moved up from Rs 359.1 to Rs 860.0, registering a gain of Rs 500.9 (up 139.5%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,508.7 to 43,755.5, registering a gain of 53.5% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 167.1%), SUVEN PHARMACEUTICALS (up 113.1%) and Glenmark Pharma (up 95.5%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 83,264.6 (up 0.4%).

The top gainers among the BSE Sensex today are NTPC (up 2.5%) and Kotak Bank (up 1.9%). The most traded stocks in the BSE Sensex are NTPC and Tata Steel.

In the meantime, NSE Nifty is at 25,438.4 (up 0.2%). NTPC and Kotak Bank are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 67,596.8 to 83,264.6, registering a gain of 15,667.7 points (up 23.2%).

SHILPA MEDICARE Financial Update...

SHILPA MEDICARE net profit grew 519.2% YoY to Rs 176 million for the quarter ended June 2024, compared to a profit of Rs 28 million a year ago. Net sales rose 12.4% to Rs 2,925 million during the period as against Rs 2,602 million in April-June 2023.

For the year ended March 2024, SHILPA MEDICARE reported 203.4% increase in net profit to Rs 320 million compared to net loss of Rs 309 million during FY23. Revenue of the company grew 9.7% to Rs 11,516 million during FY24.

The current Price to earnings ratio of SHILPA MEDICARE, based on rolling 12 month earnings, stands at 163.4.


Equitymaster requests your view! Post a comment on "SHILPA MEDICARE Plunges 6%; BSE HEALTHCARE Index Down 0.0%". Click here!